Dachaigh › Neoplasm a rèir Seòrsa Histologic
Sgrùdaidhean clionaigeach Neoplasm a rèir Seòrsa Histologic a’ fastadh anns na SA
Tha 12 sgrùdaidhean airson Neoplasm a rèir Seòrsa Histologic a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Atlanta, GA5 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Chicago, IL4 sgrùdaidhean
- St. Louis, MO3 sgrùdaidhean
- Baldwin Park, CA3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Nashville, TN3 sgrùdaidhean
- Tampa, FL3 sgrùdaidhean
- Dallas, TX3 sgrùdaidhean
- Clifton, NJ3 sgrùdaidhean
Le stàit
- California7 sgrùdaidhean
- Florida6 sgrùdaidhean
- Georgia6 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Michigan4 sgrùdaidhean
- Missouri4 sgrùdaidhean
- New Jersey5 sgrùdaidhean
- New York3 sgrùdaidhean
- Ohio4 sgrùdaidhean
- Tennessee4 sgrùdaidhean
- Texas6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05874921Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
A’ fastadhÌre 1/2
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07416188HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07075185Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04104776Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT04198766Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06463665A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT03093116Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT05297734A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Lùna 2024 · NCT06271252Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.